Marker Therapeutics Inc (MRKR)

[Phantom Lord]

What's dilution matter when management already has shareholders down 90%?

Dilution always matters. Obviously shareholder value was wiped out but to then add dilution on top of that would have been even worse. Without this deal, that would have been their only option.

$19mn is a drop in the bucket for a biotech in PI/ll. It pays salaries and keeps the lights on. They'll still need to raise for any real trial.

What part of cash runway out to 2025 do you not understand? This includes the trials they are currently running plus the pancreatic trial they will be starting. Don't forget the grants they have and the others they are waiting to hear back on. They will not need to raise additional cash to fund the existing trials. I know you don't know this but given how cheap their therapy is to manufacture the entire PII AML trial will only cost ~$25M. Full disclosure, I believe this number was provided prior to the MRD group being added. Now if we take into account the ~$15M in grants they received for this trial it will cost them ~$10M. The lymphoma and pancreatic trials, since they are a fraction of the size of the AML trial will also be minimal cost. They are waiting to hear about a grant for the pancreatic trial so if they get it then the cost will be reduced even further.

Assuming their T product had / has anything at all sellable, they should've raised without the predictably damaging rs.

Now you are assuming that a capital raise prior to the pending RS would have prevented the RS. Share price was down the drain well before the R/S. Any raise at those levels would have been just as bad as raising post RS.

Watch the now lost IP and board member owned CDMO appreciate from here.

There was no lost IP. They sold the manufacturing facilities and offloaded the manufacturing staff. They did not sell their manufacturing IP.